AVCTF

AVACTA GROUP PLC ORD NEW by Avacta Group Plc (AVCTF)

About AVACTA GROUP PLC ORD NEW by Avacta Group Plc (AVCTF)

Avacta Group Plc engages in the provision of Affimer reagents for licensing into third-party research and diagnostic products, and creates new Affimer medicines for development in-house and licensing to large pharmaceutical companies. It operates through the Life Sciences and Animal Health segments. The Life Sciences segment offers custom Affimers for reagents and diagnostics, drug and biomarker discovery in biotech research and development. The Animal Health segment includes tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The company was founded by Alastair MacLaughlin Smith, Simon Webster, and Kurt Justin Baldwin in 2003 and is headquartered in Leeds, the United Kingdom.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.33
52 Week Low
$0.48
Market cap
193.9M
Dividend yield
0.00%
Volume
--
Avg. volume
400
P/E ratio
-4.76

AVACTA GROUP PLC ORD NEW by Avacta Group Plc News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.33
52 Week Low
$0.48
Market cap
193.9M
Dividend yield
0.00%
Volume
--
Avg. volume
400
P/E ratio
-4.76